MarkLogic

Articles by MarkLogic

Latest Updated Articles

Trending on PharmExec

Modern Policy Concerns Stemming from 340B

Funding Roundup: Silence Therapeutics, AbCellera Announce IPO Pricing, Beyang, Remepy Close Series A Financing

Pharmaceutical Executive Daily: Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics

2026 Emerging Pharma Leaders

Taking a Hard Look at Pharma's Traditional Margin Model